Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-061789
Filing Date
2025-06-23
Accepted
2025-06-23 18:23:01
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518376-8_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2518376-8_3seq1.xml 3 4834
2 EXHIBIT 24 tm2518376d8_ex24.htm EX-24 6628
  Complete submission text file 0001104659-25-061789.txt   12867
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Balcom Alexandra (Reporting) CIK: 0001862147 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 251066187